Pacific Biosciences Reports Q4 Profit, Meets Expectations

Pacific Biosciences of California Inc. (PACB) reported a fourth-quarter profit of $3.6 million. The Menlo Park-based company had a net loss of 49 cents per share. Adjusted losses were 20 cents per share, in line with Wall Street expectations. Revenue reached $39.2 million.

For the year, Pacific Biosciences reported a loss of $308.7 million, with revenue of $154 million.